Cathie Wood Just This Biotech Bet: Reading the Signals
ARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
Conduct a value comparison of no annual fee cash back cards to find the right one for your spending needs. Make informed choices.
25,387 articlesARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
Redistricting battles aren’t just about politics. They can ripple through local housing markets, shaping demand, lend...
Adobe faces a pivotal shift as its own AI tool accelerates cannibalization of the stock library, forcing a rethinking...
A rally in AeroVironment shares has investors wondering what sparked the move. This guide breaks down the factors beh...
With the December 2026 deadline approaching, investors with large capital gains are weighing Qualified Opportunity Fu...
NBC’s Olympic rights are finally paying off as Milan-Cortina 2026 delivers blockbuster ratings, underscoring a vindic...
When AI-assisted reviews uncover a serious flaw in a blockchain project, markets react fast. Anthropic's just found t...
An institutional investor disclosed a new $6.5 million stake in Middleby. This article uncovers what’s behind that be...
As deal talk returns to tech, we weigh Reddit, Roku, and SoundHound AI for takeover potential. None has a confirmed b...
In close CEO searches, the runner-up often lands a multi-million retention package. This trend shows up in Disney, Mo...
Palantir maintains AI-driven momentum into 2026, but investors weigh continued growth against contracts and policy ri...
A major bet from a savvy institutional investor puts Brookdale Senior Living in the spotlight. Mason Capital Manageme...